Vanessa Barth

1.5k total citations
36 papers, 1.0k citations indexed

About

Vanessa Barth is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Vanessa Barth has authored 36 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 26 papers in Cellular and Molecular Neuroscience and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Vanessa Barth's work include Receptor Mechanisms and Signaling (20 papers), Neuroscience and Neuropharmacology Research (14 papers) and Neuropeptides and Animal Physiology (12 papers). Vanessa Barth is often cited by papers focused on Receptor Mechanisms and Signaling (20 papers), Neuroscience and Neuropharmacology Research (14 papers) and Neuropeptides and Animal Physiology (12 papers). Vanessa Barth collaborates with scholars based in United States, United Kingdom and Spain. Vanessa Barth's co-authors include Karen Rash, Lee A. Phebus, Anne B. Need, Matthew A. Seager, Kurt Rasmussen, Michael A. Statnick, Victor W. Pike, Robert B. Innis, Sami S. Zoghbi and Eyassu Chernet and has published in prestigious journals such as Angewandte Chemie International Edition, NeuroImage and Biological Psychiatry.

In The Last Decade

Vanessa Barth

35 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vanessa Barth United States 21 623 578 145 121 110 36 1.0k
Robert L. Gladding United States 20 399 0.6× 347 0.6× 174 1.2× 286 2.4× 197 1.8× 46 1.3k
Tsu Tshen Chuang United Kingdom 17 810 1.3× 522 0.9× 232 1.6× 48 0.4× 140 1.3× 26 1.3k
Eryn L. Werry Australia 16 354 0.6× 293 0.5× 228 1.6× 55 0.5× 50 0.5× 44 1.1k
Songye Li United States 18 361 0.6× 376 0.7× 167 1.2× 164 1.4× 49 0.4× 49 933
Maria Antonietta Stasi Italy 16 361 0.6× 351 0.6× 65 0.4× 36 0.3× 65 0.6× 31 814
Athanasios Metaxas Denmark 17 314 0.5× 263 0.5× 257 1.8× 58 0.5× 98 0.9× 40 723
Patrick N. McCormick Canada 15 418 0.7× 515 0.9× 77 0.5× 172 1.4× 63 0.6× 22 978
Rikki N. Waterhouse United States 20 872 1.4× 617 1.1× 92 0.6× 278 2.3× 143 1.3× 46 1.4k
Sean M. Peterson United States 14 820 1.3× 627 1.1× 65 0.4× 109 0.9× 35 0.3× 23 1.1k
Michael Kapinos United States 15 186 0.3× 293 0.5× 120 0.8× 112 0.9× 154 1.4× 33 687

Countries citing papers authored by Vanessa Barth

Since Specialization
Citations

This map shows the geographic impact of Vanessa Barth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vanessa Barth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vanessa Barth more than expected).

Fields of papers citing papers by Vanessa Barth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vanessa Barth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vanessa Barth. The network helps show where Vanessa Barth may publish in the future.

Co-authorship network of co-authors of Vanessa Barth

This figure shows the co-authorship network connecting the top 25 collaborators of Vanessa Barth. A scholar is included among the top collaborators of Vanessa Barth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vanessa Barth. Vanessa Barth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Krämer, Martina, Vanessa Barth, Thomas Haas, et al.. (2024). The P(III)‐Amidite Based Synthesis of Stable Isotope Labeled mRNA‐Cap‐Structures Enables their Sensitive Quantitation from Brain Tissue. Angewandte Chemie International Edition. 64(2). e202414537–e202414537. 2 indexed citations
3.
Barth, Vanessa, et al.. (2022). The articular cartilage surface is impaired by a loss of thick collagen fibers and formation of type I collagen in early osteoarthritis. Acta Biomaterialia. 146. 274–283. 37 indexed citations
4.
Nabulsi, Nabeel, Daniel Holden, Ming‐Qiang Zheng, et al.. (2019). Evaluation of11C-LSN3172176 as a Novel PET Tracer for Imaging M1Muscarinic Acetylcholine Receptors in Nonhuman Primates. Journal of Nuclear Medicine. 60(8). 1147–1153. 16 indexed citations
5.
Paul, Soumen, Mohammad B. Haskali, Jeih-San Liow, et al.. (2018). Evaluation of a PET Radioligand to Image O-GlcNAcase in Brain and Periphery of Rhesus Monkey and Knock-Out Mouse. Journal of Nuclear Medicine. 60(1). 129–134. 27 indexed citations
6.
Mogg, Adrian J., Thomas E. Eessalu, Megan Johnson, et al.. (2018). In Vitro Pharmacological Characterization and In Vivo Validation of LSN3172176 a Novel M1 Selective Muscarinic Receptor Agonist Tracer Molecule for Positron Emission Tomography. Journal of Pharmacology and Experimental Therapeutics. 365(3). 602–613. 8 indexed citations
7.
Bakker, Geor, Kora de Bruin, Jos Eersels, et al.. (2015). 123I-Iododexetimide Preferentially Binds to the Muscarinic Receptor Subtype M1In Vivo. Journal of Nuclear Medicine. 56(2). 317–322. 18 indexed citations
8.
Post, Anke, Trevor Smart, Gerard R. Dawson, et al.. (2015). A Selective Nociceptin Receptor Antagonist to Treat Depression: Evidence from Preclinical and Clinical Studies. Neuropsychopharmacology. 41(7). 1803–1812. 82 indexed citations
9.
Toledo, Miguel A., Concepción Pedregal, Nuria Cirauqui, et al.. (2014). Discovery of a Novel Series of Orally Active Nociceptin/Orphanin FQ (NOP) Receptor Antagonists Based on a Dihydrospiro(piperidine-4,7′-thieno[2,3-c]pyran) Scaffold. Journal of Medicinal Chemistry. 57(8). 3418–3429. 49 indexed citations
10.
Zheng, Ming‐Qiang, Su Jin Kim, Daniel Holden, et al.. (2014). An Improved Antagonist Radiotracer for the κ-Opioid Receptor: Synthesis and Characterization of11C-LY2459989. Journal of Nuclear Medicine. 55(7). 1185–1191. 24 indexed citations
11.
Zheng, Ming‐Qiang, Nabeel Nabulsi, Su Kim, et al.. (2013). Synthesis and Evaluation of11C-LY2795050 as a κ-Opioid Receptor Antagonist Radiotracer for PET Imaging. Journal of Nuclear Medicine. 54(3). 455–463. 75 indexed citations
12.
Fisher, Matthew J., Vanessa Barth, Joseph M. Gruber, et al.. (2012). 3-Phenyl-5-isothiazole carboxamides with potent mGluR1 antagonist activity. Bioorganic & Medicinal Chemistry Letters. 22(7). 2514–2517. 21 indexed citations
13.
Zanotti‐Fregonara, Paolo, Vanessa Barth, Jeih-San Liow, et al.. (2012). Evaluation in vitro and in animals of a new 11C-labeled PET radioligand for metabotropic glutamate receptors 1 in brain. European Journal of Nuclear Medicine and Molecular Imaging. 40(2). 245–253. 16 indexed citations
14.
Lohith, Talakad G., Sami S. Zoghbi, Cheryl L. Morse, et al.. (2012). Brain and Whole-Body Imaging of Nociceptin/Orphanin FQ Peptide Receptor in Humans Using the PET Ligand 11C-NOP-1A. Journal of Nuclear Medicine. 53(3). 385–392. 56 indexed citations
15.
Kimura, Yasuyuki, Masahiro Fujita, Jinsoo Hong, et al.. (2011). Brain and Whole-Body Imaging in Rhesus Monkeys of 11C-NOP-1A, a Promising PET Radioligand for Nociceptin/Orphanin FQ Peptide Receptors. Journal of Nuclear Medicine. 52(10). 1638–1645. 42 indexed citations
17.
Barth, Vanessa, Eyassu Chernet, Anne B. Need, et al.. (2006). Comparison of rat dopamine D2 receptor occupancy for a series of antipsychotic drugs measured using radiolabeled or nonlabeled raclopride tracer. Life Sciences. 78(26). 3007–3012. 63 indexed citations
18.
Seager, Matthew A., Vanessa Barth, Lee A. Phebus, & Kurt Rasmussen. (2005). Chronic coadministration of olanzapine and fluoxetine activates locus coeruleus neurons in rats: implications for bipolar disorder. Psychopharmacology. 181(1). 126–133. 47 indexed citations
19.
Chernet, Eyassu, Laura J. Martin, Anne B. Need, et al.. (2005). Use of LC/MS to assess brain tracer distribution in preclinical, in vivo receptor occupancy studies: Dopamine D2, serotonin 2A and NK-1 receptors as examples. Life Sciences. 78(4). 340–346. 63 indexed citations
20.
Seager, Matthew A., et al.. (2004). Fluoxetine administration potentiates the effect of olanzapine on locus coeruleus neuronal activity. Biological Psychiatry. 55(11). 1103–1109. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026